|
Authors/trial code | Study design | Status and results |
|
García-Olmo et al. 2005 [59] | (phase I study) Autologous adipose derived stem cells | Trial completed 75% of fistulas have complete closure at week 8 |
Garcia-Olmo et al. 2009 [60] | (phase II study) Autologous adipose derived stem cells + fibrin glue | Trial completed Fistula healing: 71% versus 16% |
Ciccocioppo et al. 2011 [58] | (prospective study) Autologous mesenchymal stem cells | Reduction in Crohn’s disease activity index and pain/discharge scores |
Herreros et al. 2012 [61] NCT00475410 | (phase III study) Autologous adipose derived stem cells + fibrin glue | Trial completed At 1 year, the healing rates were 57.1% (stem cells alone), 52.4% (stem cells + fibrin glue), and 37.3% (fibrin glue alone) |
Molendijk et al. 2015 [64] NCT01144962 | (phase II study) Allogeneic adipose derived stem cells Placebo-control | Trial completed Healing up to 85% |
Panés et al. 2016 [62] NCT01541579 | (Phase III study) Allogeneic adipose derived stem cells versus placebo | Trial ongoing 50% versus 34% achieved combined remission |
NCT01915927 | (Phase I study) Autologous adipose derived stem cells coated fistula plug | Trial recruiting patients
|
|